z-logo
open-access-imgOpen Access
Amino Acid Composition Determines Peptide Activity Spectrum and Hot‐Spot‐Based Design of Merecidin
Author(s) -
Wang Xiuqing,
Mishra Biswajit,
Lushnikova Tamara,
Narayana Jayaram Lakshmaiah,
Wang Guangshun
Publication year - 2018
Publication title -
advanced biosystems
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.153
H-Index - 18
ISSN - 2366-7478
DOI - 10.1002/adbi.201700259
Subject(s) - antimicrobial , peptide , cathelicidin , antimicrobial peptides , bacteria , amino acid , pathogenic bacteria , biology , galleria mellonella , staphylococcus aureus , biochemistry , microbiology and biotechnology , chemistry , virulence , genetics , gene
There is a great interest in developing the only human cathelicidin into therapeutic molecules. The major antimicrobial region of human LL-37 corresponds to residues 17-32. The resultant peptide GF-17 shows a broad spectrum of antimicrobial activity against both Gram-positive and negative bacteria. By reducing the hydrophobic content, we previously succeeded in converting the broad-spectrum GF-17 to two narrow-spectrum peptides (GF-17d3 and KR-12) with activity against Gram-negative bacteria. This study demonstrates that substitution of multiple basic amino acids by hydrophobic alanines makes a broad-spectrum peptide 17BIPHE2 (designed based on GF-17d3) active against Staphylococcal pathogens but not other bacteria tested. Taken together, our results reveal distinct charge and hydrophobic requirements for peptides to kill Gram-positive or Gram-negative bacteria. This finding is in line with the bioinformatics analysis of the peptides in the Antimicrobial Peptide Database (http://aps.unmc.edu/AP). In addition, a hot spot arginine is identified and used to design merecidin with reduced toxicity to human cells. Merecidin protects wax moth larvae ( Galleria mellonella ) from the infection of methicillin-resistant S. aureus USA300. These new selective peptides constitute interesting candidates for future development.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here